The SHEN Lab

free html website templates

Team news

New article published!
A mathematical model to study the impact of intra-tumour heterogeneity on anti-tumour CD8+ T cell immune response.

Mobirise
Mobirise

New review published! 
we discuss recent advances in understanding the relationship between mRNA translation and tumor-associated immunity, the potential mechanisms of immunotherapy resistance in cancers linked to translational reprogramming, and therapeutic perspectives and potential challenges of modulating translational regulation in cancer immunotherapy.

@ Cancer Research, AACR 2021

New article published! We have developped a proximity ligation assay-based detection of mRNA translation initiation complex eIF4F in situ and single-molecule image analysis tools for cellular translation activity monitoring.
 
@ Cell Press, STAR Protocols

Mobirise

Shensi Shen discusses mathematical oncology by modeling reversible state of persistent cancer cells @ SMB2021 symposium.

@ Univ. of California, Riverside, USA

Mobirise
Mobirise

One of the most famous french media: Le Monde Made a special issue for our work on persistent cancer cells (cellules persistantes). We need more attentions from the public to revive the cancer research.

@LeMonde,Paris,France

Team members

沈慎思

Shensi Shen
Principal Investigator

李开秀

KaiXiu Li
Assitant Researcher

蒲怡

Yi Pu
Post-doc

卢天健

TianJian Lu
PhD candidate

彭皓宁

HaoNing Peng
PhD candidate

王梦瑶

Mengyao Wang
Research Assistant

王之乐

Zhile Wang
Post-doc

Our Contact

Address:

Singapore-Sichuan Frontier Medical Center
West China hospital Chest Cancer Research Institute
D5-B building, Xin-chuan Road, Chengdu City, China 610200

E-mail:

shensi.sean@gmail.com

FOLLOW US!